Interstitial Lung Disease and Sarcoidosis.

Area of Science:

• Pulmonary Medicine
• Health Disparities Research
• Fibrotic Lung Diseases

Background:

• Interstitial lung disease (ILD) is a group of disorders causing pulmonary fibrosis, affecting 200 per 100,000 in the US.
• Sarcoidosis is a multisystem inflammatory disease with varied presentations, often including pulmonary fibrosis.
• Significant health disparities exist in ILD and sarcoidosis based on socioeconomic status, race, gender, and geography.

Purpose of the Study:

• To review existing health disparities in ILD and sarcoidosis.
• To explore potential underlying determinants contributing to these disparities.
• To propose strategies for advancing health equity in these conditions.

Main Methods:

• Literature review of studies on ILD and sarcoidosis.
• Analysis of health outcome data stratified by demographic and socioeconomic factors.
• Synthesis of findings to identify patterns of health inequity.

Main Results:

• Documented disparities in diagnosis, treatment, and outcomes for ILD and sarcoidosis patients.
• Identified socioeconomic status, race, gender, and geographic location as key factors influencing disparities.
• Highlighted the need for targeted interventions to address these inequities.

Conclusions:

• Health disparities are a significant concern in ILD and sarcoidosis.
• Addressing social determinants of health is crucial for achieving equity.
• A multi-faceted approach is required to ensure equitable care for all patients.